Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$49,790.00
Jan 2, 2023
For-profit organization
Lead discovery to PTSD in-vivo Proof-of-Concept
999723
This project is focused on identifying and characterizing highly selective leads for the treatment of a psychological disorder. The latest series of unique compounds will be subjected to thorough in vitro pharmacological investigation to select the best ones for subsequent progression to scale-up and evaluation in a validated animal model.
$350,000.00
Jun 1, 2018
For-profit organization
EUREKA - Development of a Macrocyclic Inhibitor Against the Zika and Dengue Virus NS2B-NS3 Proteases
907552
This project is focused on discovering a candidate ready for entry into formal regulatory preclinical development for the prevention and treatment of flavivirus infections by blocking an enzyme vital to the viral lifecycle with a new type of chemical structure to address the significant worldwide threat posed by these pathogens.